title: Disrupted pulmonary artery cyclic guanosine monophosphate signaling in mice with hyperoxia-induced pulmonary hypertension.
abstract: Pulmonary hypertension (PH) occurs in 25 to 35% of premature infants with significant bronchopulmonary dysplasia (BPD). Neonatal mice exposed to 14 days of hyperoxia develop BPD-like lung injury and PH. To determinne the impact of hyperoxia on pulmonary artery (PA) cyclic guanosine monophosphate (cGMP) signaling in a murine model of lung injury and PH, neonatal C57BL/6 mice were placed in room air, 75% O2 for 14 days (chronic hyperoxia [CH]) or 75% O2 for 24 hours, followed by 13 days of room air (acute hyperoxia with recovery [AHR]) with or without sildenafil. At 14 days, mean alveolar area, PA medial wall thickness (MWT), right ventricular hypertrophy (RVH), and vessel density were assessed. PA protein was analyzed for cGMP, soluble guanylate cyclase, and PDE5 activity. CH and AHR mice had RVH, but only CH mice had increased alveolar area and MWT and decreased vessel density. In CH and AHR PAs, soluble guanylate cyclase activity was decreased, and PDE5 activity was increased. In CH mice, sildenafil attenuated MWT and RVH but did not improve mean alveolar area or vessel density. In CH and AHR PAs, sildenafil decreased PDE5 activity and increased cGMP. Our results indicate that prolonged hyperoxia leads to lung injury, PH, RVH, and disrupted PA cGMP signaling. Furthermore, 24 hours of hyperoxia causes RVH and disrupted PA cGMP signaling that persists for 13 days. Sildenafil reduced RVH and restored vascular cGMP signaling but did not attenuate lung injury. Thus, hyperoxia can rapidly disrupt PA cGMP signaling in vivo with sustained effects, and concurrent sildenafil therapy can be protective.
authors.affiliation: 1 Department of Pediatrics, Northwestern University, Chicago, Illinois; and.
authors.forename: Keng Jin
authors.initials: KJ
authors.lastname: Lee
authors.forename: Sara K
authors.initials: SK
authors.lastname: Berkelhamer
authors.forename: Gina A
authors.initials: GA
authors.lastname: Kim
authors.forename: Joann M
authors.initials: JM
authors.lastname: Taylor
authors.forename: Kelly M
authors.initials: KM
authors.lastname: O'Shea
authors.forename: Robin H
authors.initials: RH
authors.lastname: Steinhorn
authors.forename: Kathryn N
authors.initials: KN
authors.lastname: Farrow
mesh_terms: D000818:Animals; D006152:Cyclic GMP / Q000378:metabolism; D006157:Guanosine Monophosphate / Q000378:metabolism*; D018496:Hyperoxia / Q000150:complications / Q000378:metabolism*; D006976:Hypertension, Pulmonary / Q000188:drug therapy* / Q000209:etiology / Q000378:metabolism; D008168:Lung / Q000378:metabolism; D055370:Lung Injury / Q000188:drug therapy / Q000378:metabolism; D051379:Mice; D008810:Mice, Inbred C57BL; D010879:Piperazines / Q000494:pharmacology*; D011651:Pulmonary Artery / Q000378:metabolism* / Q000473:pathology; D011687:Purines / Q000494:pharmacology; D015398:Signal Transduction / Q000187:drug effects / Q000502:physiology; D000068677:Sildenafil Citrate; D013450:Sulfones / Q000494:pharmacology*
chemical_list: D010879:Piperazines; D011687:Purines; D013450:Sulfones; D006157:Guanosine Monophosphate; D000068677:Sildenafil Citrate; D006152:Cyclic GMP
references.citation: Antioxid Redox Signal. 2012 Aug 1;17(3):460-70
references.pmid: 22229392
references.citation: Am J Physiol Lung Cell Mol Physiol. 2005 Nov;289(5):L798-806
references.pmid: 15964898
references.citation: J Anat. 1977 Sep;124(Pt 1):131-51
references.pmid: 914698
references.citation: Am J Respir Crit Care Med. 2005 Sep 15;172(6):750-6
references.pmid: 15947285
references.citation: Am J Respir Crit Care Med. 2013 Mar 15;187(6):572-5
references.pmid: 23220921
references.citation: Am J Respir Cell Mol Biol. 2013 Feb;48(2):iii-v
references.pmid: 23378489
references.citation: Handb Exp Pharmacol. 2011;(204):251-77
references.pmid: 21695644
references.citation: J Perinatol. 2012 Jan;32(1):64-9
references.pmid: 21941230
references.citation: Am J Respir Crit Care Med. 2009 Dec 1;180(11):1122-30
references.pmid: 19713447
references.citation: Thorax. 1982 Aug;37(8):564-71
references.pmid: 7179184
references.citation: Pediatrics. 2011 Nov;128(5):e1216-25
references.pmid: 22007016
references.citation: Circulation. 2005 Oct 18;112(16):2477-86
references.pmid: 16230500
references.citation: J Perinatol. 2013 Jul;33(7):553-7
references.pmid: 23328924
references.citation: Am J Physiol Lung Cell Mol Physiol. 2010 Mar;298(3):L315-23
references.pmid: 20008116
references.citation: J Pediatr. 2009 Dec;155(6):841-847.e1
references.pmid: 19836028
references.citation: J Perinatol. 2012 Jan;32(1):1-3
references.pmid: 22202953
references.citation: Xenobiotica. 1999 Mar;29(3):297-310
references.pmid: 10219969
references.citation: N Engl J Med. 1999 Jun 24;340(25):1962-8
references.pmid: 10379020
references.citation: Pediatrics. 2007 Dec;120(6):1260-9
references.pmid: 18055675
references.citation: Korean Circ J. 2010 Mar;40(3):131-6
references.pmid: 20339498
references.citation: Respir Res. 2009 Apr 29;10:30
references.pmid: 19402887
references.citation: J Pediatr. 2009 Mar;154(3):379-84, 384.e1-2
references.pmid: 18950791
references.citation: Circulation. 2012 Jan 17;125(2):324-34
references.pmid: 22128226
references.citation: Neuroscience. 2011 Oct 13;193:399-410
references.pmid: 21820491
references.citation: Am J Physiol. 1998 Jul;275(1):L110-7
references.pmid: 9688942
references.citation: Pediatrics. 2006 Apr;117(4):1077-83
references.pmid: 16585301
references.citation: N Engl J Med. 2006 Jul 27;355(4):343-53
references.pmid: 16870913
references.citation: Am J Physiol Lung Cell Mol Physiol. 2010 Jul;299(1):L109-16
references.pmid: 20400523
references.citation: Am J Pathol. 2011 Jun;178(6):2601-10
references.pmid: 21550015
references.citation: Am J Respir Cell Mol Biol. 2013 Jan;48(1):105-13
references.pmid: 23065129
references.citation: Am J Physiol Lung Cell Mol Physiol. 2007 May;292(5):L1073-84
references.pmid: 17209139
references.citation: J Pharmacol Exp Ther. 1997 Nov;283(2):619-24
references.pmid: 9353377
references.citation: N Engl J Med. 2006 May 18;354(20):2112-21
references.pmid: 16707748
references.citation: N Engl J Med. 2006 Jul 27;355(4):354-64
references.pmid: 16870914